Thrive Capital Partners VII Growth, L.P. bought $5.4M of Oscar Health (OSCR)
Executed Nov 14 2024, disclosed Nov 18 2024, 4 days later.
Over the 21 trading sessions from the disclosed entry session (Nov 18 2024), the stock returned -12.1% (delay-adjusted); from the execution session (Nov 14 2024), -8.7%. Derived: entry at the session's open, exit at the close 20 sessions later.
Thrive Capital Partners VII Growth, L.P. (Director) filed 1 Form 4 report as a reporting entity in the past 24 months (1 purchase, 0 sales), most often in Oscar Health, Inc. (OSCR). Across 1 priced purchase filing, the average 21-session return was -8.7% from execution and -12.1% from disclosure (delay-adjusted; derived). The largest single filing was $5.4M of OSCR (344,522 sh across 2 lots, as filed), executed Nov 14 2024.
Healthcare · Oscar Health, Inc. operates as a healthcare technology company in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→